Breast and prostate cancer survival worsens with metabolic syndrome

	Breast Cancer
	The latest breast cancer news from News Medical

	Breast and prostate cancer survival worsens with metabolic syndrome A SEER-Medicare analysis of more than 200,000 adults aged 66 and older found that metabolic syndrome was associated with about twice the adjusted hazard of death from any cause after breast or prostate cancer. The condition was also linked to higher cancer-specific, cardiovascular-specific, and liver-failure-specific mortality, although the observational design prevents causal conclusions.

	Global hotspots where breast cancer and atrial fibrillation overlap Investigating breast cancer and atrial fibrillation overlap, this study highlights key risk factors, underscoring the need for integrated prevention approaches.

			New model improves short- and long-term disease risk prediction Researchers developed ALADYNOULLI, a Bayesian generative model that combines longitudinal health records, age, and polygenic risk to identify reproducible disease signatures across more than 683,000 participants. In UK Biobank testing, the framework achieved stronger short- and long-term risk discrimination than established clinical scores while revealing disease subgroups and genetic associations.

			Global cancer cases projected to reach nearly 35 million by 2050 Millions of people are facing physical, emotional and financial toll of cancer, a disease that claims more than 26 000 lives every day, according to a report released today by the World Health Organization (WHO).

			Bile acid buildup linked to aggressive breast cancer progression A buildup of bile acids caused by an unhealthy gut can drive breast cancer to other parts of the body, new University of Virginia Comprehensive Cancer Center research reveals.

	LIG1 loss reveals new treatment strategy for aggressive breast cancer Loss of one copy of the DNA Ligase I (LIG1) gene in triple-negative breast cancers (TNBC) with TP53 mutations confers resistance to chemotherapy, but researchers at Baylor College of Medicine and collaborating institutions have identified a vulnerability in these cells and used it to their advantage.

	Study highlights breast screening barriers facing Black women in Britain Black African and Black Caribbean women in the UK want clearer and more accessible information about breast cancer screening, according to a study from the University of Surrey.

	Weill Cornell Medicine receives DoD grant to target triple-negative breast cancer Weill Cornell Medicine has received a $2.5 million, three-year grant from the Department of Defense (DoD) to develop therapies with fewer side effects for triple-negative breast cancer, one of the most aggressive and difficult-to-treat breast cancers.

	Researchers at Tulane University School of Medicine strengthen breast cancer research workflows with advanced liquid handling Advanced liquid handling tools from INTEGRA Biosciences are transforming breast cancer research at Tulane, boosting accuracy and workflow efficiency in the lab.

	G&H highlights end-to-end diagnostic device development at ADLM 2026 At the ADLM Clinical Lab Expo 2026, G&H will showcase how diagnostic and medical device companies can accelerate the development and commercialization of innovative healthcare technologies through a single partner offering multidisciplinary engineering, precision optics, photonics and ISO 13485-certified manufacturing.

Why did you receive this email?
You are receiving this email because you subscribed to updates from AZoNetwork UK Ltd. on one of our websites and requested to be notified of additional information.

Unsubscribe or Update Notification Preferences

Contact | About | Privacy Policy

- - - - - -

Registered Address:
AZoNetwork UK Ltd.,

Manchester | Sydney | Boston

Copyright © 2000-2026